BRCA1 and ovarian cancer: Recent studies on BRCA1/BRCA2 have concluded that a germline mutation in BRCA1 or BRCA2 was associated with improved survival in ovarian cancer patients and BRCA2 carriers had the best prognosis (40–, 42).